Jim Cramer on Inspire Medical: “They’ve Had One Execution Issue After Another”

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the stocks Jim Cramer put under the spotlight. Cramer highlighted that GLP-1s are negatively impacting the company, as he remarked: “Management wasn’t able to quantify the impact, and they continue to insist that GLP-1s will be a long-term positive because tons of people are actually too obese to get Inspire’s implant. They argue that the GLP-1s will increase their total adjustable market by helping those people lose weight. I’m not buying this one bit. ...